• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸二酯酶(PDE)抑制的效力、选择性及非选择性的后果

Potency, selectivity, and consequences of nonselectivity of PDE inhibition.

作者信息

Bischoff E

机构信息

Bayer Pharma Research, Bayer Healthcare Wuppertal, PH-R-EU-CV-ll, Wuppertal, Germany.

出版信息

Int J Impot Res. 2004 Jun;16 Suppl 1:S11-4. doi: 10.1038/sj.ijir.3901208.

DOI:10.1038/sj.ijir.3901208
PMID:15224129
Abstract

Phosphodiesterases (PDEs) play a decisive role in cyclic nucleotide-mediated intracellular signaling. As PDEs are expressed in a variety of tissues, selectivity is a prerequisite for a therapeutically applicable PDE inhibitor. Sildenafil, vardenafil, and tadalafil are selective for PDE5, with vardenafil exhibiting the highest potency and minimal inhibition of other PDEs, with the exception of PDE6. Tadalafil is extremely selective for PDE5, but also potently inhibits PDE11, an enzyme with unknown physiological function. As PDE1 is expressed in the brain, myocardium, and vascular smooth muscle cells, nonselectivity with respect to this enzyme (selectivity: tadalafil>vardenafil>sildenafil) may result in vasodilation and tachycardia. Inhibition of PDE6 (selectivity: tadalafil>vardenafil congruent with sildenafil), which is expressed only in retina and functions in visual transduction, can transiently disturb vision. PDE5 inhibitors may also indirectly inhibit PDE3 by increasing cyclic guanosine monophospate levels, thereby elevating heart rate and vasodilation while inhibiting platelet aggregation.

摘要

磷酸二酯酶(PDEs)在环核苷酸介导的细胞内信号传导中起决定性作用。由于PDEs在多种组织中表达,因此选择性是治疗用PDE抑制剂的先决条件。西地那非、伐地那非和他达拉非对PDE5具有选择性,其中伐地那非效力最高,对其他PDEs(PDE6除外)的抑制作用最小。他达拉非对PDE5具有极高的选择性,但也能有效抑制PDE11,这是一种生理功能未知的酶。由于PDE1在脑、心肌和血管平滑肌细胞中表达,对该酶的非选择性(选择性:他达拉非>伐地那非>西地那非)可能导致血管舒张和心动过速。仅在视网膜中表达并在视觉转导中起作用的PDE6的抑制作用(选择性:他达拉非>伐地那非与西地那非相当)可暂时干扰视力。PDE5抑制剂还可能通过增加环磷酸鸟苷水平间接抑制PDE3,从而在抑制血小板聚集的同时提高心率和血管舒张。

相似文献

1
Potency, selectivity, and consequences of nonselectivity of PDE inhibition.磷酸二酯酶(PDE)抑制的效力、选择性及非选择性的后果
Int J Impot Res. 2004 Jun;16 Suppl 1:S11-4. doi: 10.1038/sj.ijir.3901208.
2
Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.氚标记的西地那非、他达拉非或伐地那非与磷酸二酯酶-5催化位点的结合表现出效力、特异性、异质性及环磷酸鸟苷(cGMP)刺激作用。
Mol Pharmacol. 2004 Jul;66(1):144-52. doi: 10.1124/mol.66.1.144.
3
Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.5型磷酸二酯酶抑制剂在勃起功能障碍和心血管疾病治疗中的应用
Cardiol Rev. 2007 Mar-Apr;15(2):76-86. doi: 10.1097/01.crd.0000233904.77128.49.
4
Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms.使用磷酸二酯酶-5抑制剂治疗良性前列腺增生和下尿路症状的临床前证据。
BJU Int. 2006 Dec;98(6):1259-63. doi: 10.1111/j.1464-410X.2006.06501.x. Epub 2006 Sep 6.
5
Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.勃起功能障碍:磷酸二酯酶-5抑制剂西地那非、伐地那非和他达拉非的疗效及副作用比较——文献综述
Eur J Med Res. 2002 Oct 29;7(10):435-46.
6
Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events.伐地那非临床前试验数据:效能、药效学、药代动力学及不良事件。
Int J Impot Res. 2004 Jun;16 Suppl 1:S34-7. doi: 10.1038/sj.ijir.3901213.
7
Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.磷酸二酯酶 5 抑制剂在肺动脉高压中的应用。
Adv Ther. 2009 Sep;26(9):813-25. doi: 10.1007/s12325-009-0064-z. Epub 2009 Sep 19.
8
High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients.他达拉非、西地那非和伐地那非对人磷酸二酯酶5A1(PDE5)的生化选择性高于PDE11A4,这表明患者不存在PDE11A4交叉反应。
Int J Impot Res. 2005 Jan-Feb;17(1):5-9. doi: 10.1038/sj.ijir.3901283.
9
Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus.5型磷酸二酯酶抑制剂用于治疗糖尿病患者的勃起功能障碍。
Int J Impot Res. 2002 Dec;14(6):466-71. doi: 10.1038/sj.ijir.3900910.
10
Phosphodiesterase 5 inhibitors for erectile dysfunction.用于治疗勃起功能障碍的磷酸二酯酶5抑制剂。
Ann Pharmacother. 2005 Jul-Aug;39(7-8):1286-95. doi: 10.1345/aph.1E487. Epub 2005 Jun 7.

引用本文的文献

1
Discovery of Natural Phosphodiesterase 5 Inhibitors from Pierre Leaves Using LC-QTOF-MS.利用液相色谱-四极杆飞行时间质谱法从皮埃尔叶中发现天然磷酸二酯酶5抑制剂
Plants (Basel). 2025 May 29;14(11):1652. doi: 10.3390/plants14111652.
2
Impact of Second-Generation PDE 5 Inhibitor, Avanafil, on Retinal Function: Studies From Ex Vivo ERG.第二代磷酸二酯酶5抑制剂阿伐那非对视网膜功能的影响:离体视网膜电图研究
Invest Ophthalmol Vis Sci. 2025 Jun 2;66(6):14. doi: 10.1167/iovs.66.6.14.
3
Regulatory effects of resveratrol on nitric oxide signaling in cardiovascular diseases.
白藜芦醇对心血管疾病中一氧化氮信号通路的调节作用。
Pharmacol Rep. 2025 Apr;77(2):355-374. doi: 10.1007/s43440-025-00694-w. Epub 2025 Jan 20.
4
Role of interaction mode of phenanthrene derivatives as selective PDE5 inhibitors using molecular dynamics simulations and quantum chemical calculations.利用分子动力学模拟和量子化学计算研究菲衍生物作为选择性磷酸二酯酶5抑制剂的相互作用模式的作用
Mol Divers. 2025 Apr;29(2):1683-1696. doi: 10.1007/s11030-024-10944-3. Epub 2024 Jul 30.
5
HDAC9 Deficiency Upregulates cGMP-dependent Kinase II to Mitigate Neuronal Apoptosis in Ischemic Stroke.组蛋白去乙酰化酶9缺乏上调环磷酸鸟苷依赖性蛋白激酶II以减轻缺血性脑卒中的神经元凋亡
Transl Stroke Res. 2025 Jun;16(3):868-881. doi: 10.1007/s12975-024-01272-7. Epub 2024 Jun 28.
6
Novel drug therapy of acute hepatic failure induced in rats by a combination of tadalafil and Lepidium sativum.他达拉非联合刺山柑治疗大鼠急性肝衰竭的新药疗法。
BMC Complement Med Ther. 2024 Feb 27;24(1):104. doi: 10.1186/s12906-024-04406-4.
7
Phosphodiesterase in heart and vessels: from physiology to diseases.心脏和血管中的磷酸二酯酶:从生理学到疾病。
Physiol Rev. 2024 Apr 1;104(2):765-834. doi: 10.1152/physrev.00015.2023. Epub 2023 Nov 16.
8
Optimizing metabolic stability of phosphodiesterase 5 inhibitors: Discovery of a potent N-(pyridin-3-ylmethyl)quinoline derivative targeting synaptic plasticity.优化磷酸二酯酶 5 抑制剂的代谢稳定性:针对突触可塑性的强效 N-(吡啶-3-基甲基)喹啉衍生物的发现。
Bioorg Med Chem Lett. 2023 Aug 15;92:129409. doi: 10.1016/j.bmcl.2023.129409. Epub 2023 Jul 13.
9
Fabric phase sorptive extraction coupled with UPLC-ESI-MS/MS method for fast and sensitive quantitation of tadalafil in a bioequivalence study.织物相吸附萃取结合超高效液相色谱-电喷雾串联质谱法用于生物等效性研究中他达拉非的快速灵敏定量分析。
Saudi Pharm J. 2022 Aug;30(8):1143-1152. doi: 10.1016/j.jsps.2022.06.001. Epub 2022 Jun 18.
10
Nanoparticle Delivery of Novel PDE4B Inhibitor for the Treatment of Alcoholic Liver Disease.新型PDE4B抑制剂的纳米颗粒递送用于治疗酒精性肝病
Pharmaceutics. 2022 Sep 7;14(9):1894. doi: 10.3390/pharmaceutics14091894.